Does Tylenol 3 (acetaminophen with codeine) show up as opioids on a Urine Drug Screen (UDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tylenol 3 Detection on Urine Drug Screens

Yes, Tylenol 3 (acetaminophen with codeine) will show up as an opioid on standard urine drug screens because codeine is detected by the opiate immunoassay panel of most standard urine drug tests. 1, 2

How Codeine is Detected on UDS

  • Standard urine drug screens (UDS) use immunoassay technology that detects morphine and codeine in the "opiates" category 1, 2
  • Codeine is the active opioid ingredient in Tylenol 3 3
  • Detection window for codeine in urine is typically 1-3 days after use 2
  • The standard 10-panel urine drug screen includes testing for opiates, which will detect codeine 2

Important Considerations for Interpretation

Metabolic Pathways

  • Codeine is metabolized to morphine in the body, so both substances may appear in the urine 4
  • Interestingly, codeine can also be metabolized to hydrocodone in small amounts (up to 11% of parent drug concentration) 4
  • This means a patient taking only Tylenol 3 might test positive for:
    • Codeine (primary drug)
    • Morphine (major metabolite)
    • Hydrocodone (minor metabolite) 4

Potential Pitfalls in Interpretation

  • False positives are possible with immunoassay screening tests 2
  • The acetaminophen component of Tylenol 3 will not affect the opiate portion of the UDS 5
  • Standard opiate screens detect morphine and codeine but may not detect synthetic opioids like oxycodone or hydrocodone without specific testing 6, 7
  • Confirmatory testing using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) is recommended to verify positive screening results 2, 8

Clinical Implications

  • When monitoring patients on chronic opioid therapy, UDS should be performed at baseline and at least annually 1, 2

  • Finding codeine in a UDS indicates either:

    1. Prescribed use of codeine-containing products like Tylenol 3
    2. Illicit/non-prescribed codeine use
    3. Possible heroin use (as heroin metabolizes to morphine with possible codeine impurities) 9
  • Unexpected UDS results should prompt a conversation with the patient rather than immediate punitive action 10, 2

  • Clinicians should establish a working relationship with laboratory toxicologists to assist with result interpretation 10, 2

Bottom Line

For healthcare providers interpreting UDS results, a positive opiate test in a patient taking Tylenol 3 is expected and consistent with appropriate medication use. Confirmatory testing can differentiate between various opioids when needed for clinical decision-making.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.